T. Ishii

发表

Clinical usefulness of fractional exhaled nitric oxide for diagnosing prolonged cough.

M. Munakata, Suguru Sato, J. Saito, 2008, Respiratory Medicine.

, FEV 1 , and Fractional Exhaled Nitric Oxide

M. Munakata, Suguru Sato, J. Saito, 2013 .

Mice with osteopontin deletion remain predisposed to collagen-induced arthritis.

Y. Saeki, I. Kawase, L. Liaw, 2004, Arthritis and rheumatism.

Osteopontin as a positive regulator in the osteoclastogenesis of arthritis.

Y. Saeki, I. Kawase, L. Liaw, 2004, Biochemical and biophysical research communications.

Efficacy and safety of ixekizumab treatment for Japanese patients with moderate to severe plaque psoriasis, erythrodermic psoriasis and generalized pustular psoriasis: Results from a 52‐week, open‐label, phase 3 study (UNCOVER‐J)

H. Nakagawa, K. Sayama, Koichiro Nakamura, 2016, The Journal of dermatology.

Efficacy and safety of open‐label ixekizumab treatment in Japanese patients with moderate‐to‐severe plaque psoriasis, erythrodermic psoriasis and generalized pustular psoriasis

H. Nakagawa, T. Ishii, M. Heffernan, 2015, Journal of the European Academy of Dermatology and Venereology : JEADV.

Safety Profile of Baricitinib in Patients with Active Rheumatoid Arthritis with over 2 Years Median Time in Treatment

M. Genovese, J. Smolen, K. Winthrop, 2018, The Journal of Rheumatology.

Intravital two-photon imaging: a versatile tool for dissecting the immune system

Masaru Ishii, M. Ishii, T. Ishii, 2011, Annals of the rheumatic diseases.

Efficacy and safety of baricitinib in Japanese patients with active rheumatoid arthritis: A 52-week, randomized, single-blind, extension study

Yoshiya Tanaka, T. Ishii, W. Macias, 2018, Modern rheumatology.

The Use of patient Reported Outcome Measures for Rheumatoid Arthritis in Japan: A Systematic Literature Review

T. Treuer, T. Ishii, B. Crawford, 2017, The open rheumatology journal.

Spontaneous perirenal hematoma due to Wegener’s granulomatosis after initiation of immunosuppressant

Y. Saeki, T. Ishii, Y. Katada, 2011, Modern rheumatology.

Baricitinib versus Placebo or Adalimumab in Rheumatoid Arthritis

D. M. van der Heijde, M. Weinblatt, E. Keystone, 2017, The New England journal of medicine.

Enhanced local production of osteopontin in rheumatoid joints.

Y. Saeki, I. Kawase, H. Matsuno, 2002, The Journal of rheumatology.

Pulmonary fibrosis in dyskeratosis congenita with TINF2 gene mutation

M. Munakata, Suguru Sato, J. Saito, 2013, European Respiratory Journal.

Four cases of Trousseau's syndrome associated with lung adenocarcinoma.

M. Munakata, Yasuko Sato, T. Ishii, 2012, Internal medicine.

A case of multicentric Castleman's disease demonstrating severe eosinophilia and enhanced production of interleukin‐5

M. Ishii, Y. Saeki, T. Ishii, 2003, European journal of haematology.

Efficacy and safety of baricitinib in Japanese patients with rheumatoid arthritis: Subgroup analyses of four multinational phase 3 randomized trials

Yoshiya Tanaka, T. Takeuchi, T. Ishii, 2018, Modern rheumatology.

Baricitinib Versus Placebo or Adalimumab in Patients with Active Rheumatoid Arthritis (RA) and an Inadequate Response to Background Methotrexate Therapy: Results of a Phase 3 Study

M. Weinblatt, E. Keystone, D. Heijde, 2015 .

Pulmonary capillary bleeding in a patient with severe left ventricular failure after acute myocardial infarction under anti-thrombotic therapy.

M. Munakata, M. Oikawa, T. Ishii, 2007, Internal medicine.

Safety profile of baricitinib in Japanese patients with active rheumatoid arthritis with over 1.6 years median time in treatment: An integrated analysis of Phases 2 and 3 trials

Yoshiya Tanaka, Y. Isaka, J. Smolen, 2020, Modern rheumatology.

Successful treatment of acquired hemophilia A, complicated by chronic GVHD, with tocilizumab

M. Kawai, T. Hirano, K. Hagihara, 2011, Modern rheumatology.

Possibility of preventive treatment for EBV-associated NK cell-lineage proliferative disorders.

M. Ishii, Y. Saeki, I. Kawase, 2003, Internal medicine.

A possible mechanism of NK cell-lineage granular lymphocyte proliferative disorder (NK-GLPD) in a patient with chronic active Epstein-Barr virus infection (CAEBV) and severe hypersensitivity to mosquito bites (SHMB).

M. Ishii, Y. Saeki, H. Asada, 2002, Internal medicine.

Enhanced production of osteopontin in multiple myeloma: clinical and pathogenic implications

H. Asaoku, H. Kitayama, A. Ogata, 2003, British journal of haematology.

[Streptococcus toxic shock syndrome with severe pleuro-pulmonary necrosis].

M. Munakata, Suguru Sato, J. Saito, 2008, Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine.

Usefulness Of Quantifying Specific IgG Antibodies By UniCAP System

M. Munakata, Suguru Sato, J. Saito, 2010, ATS 2010.

Interferon-α Acts on the S/G2/M Phases to Induce Apoptosis in the G1 Phase of an IFNAR2-expressing Hepatocellular Carcinoma Cell Line*

H. Eguchi, H. Ishii, Y. Doki, 2014, The Journal of Biological Chemistry.

Cell Cycle-Dependent Rho GTPase Activity Dynamically Regulates Cancer Cell Motility and Invasion In Vivo

K. Mimori, H. Ishii, Y. Doki, 2013, PloS one.

Diagnostic usefulness of bronchoalveolar lavage in Hermansky-Pudlak syndrome: a case with double lung cancers.

M. Munakata, Kumi Takahashi, Suguru Sato, 2004, Internal medicine.

Isolation and expression profiling of genes upregulated in the peripheral blood cells of systemic lupus erythematosus patients.

Y. Saeki, H. Onda, I. Kawase, 2005, DNA research : an international journal for rapid publication of reports on genes and genomes.

Tocilizumab, a humanized anti-interleukin-6 receptor antibody, ameliorated clinical symptoms and MRI findings of a patient with ankylosing spondylitis

Y. Shima, A. Ogata, Toshio Tanaka, 2011, Modern rheumatology.

[Monoclonal antibody therapy for rheumatoid arthritis].

Y. Saeki, T. Ishii, 2002, Nihon rinsho. Japanese journal of clinical medicine.

Use of intravital microscopy and in vitro chemotaxis assays to study the roles of sphingosine-1-phosphate in bone homeostasis.

M. Ishii, T. Ishii, J. Kikuta, 2012, Methods in molecular biology.

The role of sphingosine 1-phosphate in migration of osteoclast precursors; an application of intravital two-photon microscopy

M. Ishii, T. Ishii, J. Kikuta, 2011, Molecules and cells.

Control of osteoclast precursor migration: A novel point of control for osteoclastogenesis and bone homeostasis

M. Ishii, T. Ishii, J. Kikuta, 2010 .

Validation Study of Algorithms to Identify Malignant Tumors and Serious Infections in a Japanese Administrative Healthcare Database

T. Ishii, Masaki Nakamura, Daisuke Koide, 2021 .

Efficacy and safety of baricitinib in Japanese patients with autoinflammatory type I interferonopathies (NNS/CANDLE, SAVI, And AGS)

T. Ishii, R. Nishikomori, N. Kanazawa, 2023, Pediatric Rheumatology.

Interferon- Acts on the S/G 2 /M Phases to Induce Apoptosis in the G 1 Phase of an IFNAR2-expressing Hepatocellular

H. Eguchi, H. Ishii, Y. Doki, 2014 .

AB0249 SAFETY OF BARICITINIB IN JAPANESE PATIENTS WITH RHEUMATOID ARTHRITIS (RA): THE 2020 INTERIM REPORT FROM ALL-CASE POST MARKETING SURVEILLANCE IN CLINICAL PRACTICE

H. Matsuno, T. Atsumi, N. Tamura, 2021 .

Validation study of asthma screening criteria based on subjective symptoms and fractional exhaled nitric oxide.

M. Munakata, Suguru Sato, J. Saito, 2011, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.

Association of Asthma Education with Asthma Control Evaluated by Asthma Control Test, FEV1, and Fractional Exhaled Nitric Oxide

M. Munakata, Suguru Sato, J. Saito, 2013, The Journal of asthma : official journal of the Association for the Care of Asthma.

A phase II trial of erlotinib monotherapy for pretreated elderly patients with advanced EGFR wild-type non-small cell lung cancer

M. Munakata, T. Ishii, Y. Tanino, 2015, BMC Research Notes.

RANKL‐Induced Expression of Tetraspanin CD9 in Lipid Raft Membrane Microdomain Is Essential for Cell Fusion During Osteoclastogenesis

M. Ishii, Y. Saeki, M. Koike, 2006, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Real-world clinical outcomes of treatment with casirivimab-imdevimab among patients with mild-to-moderate coronavirus disease 2019 during the Delta variant pandemic

Yasuhiko Tsukada, J. Saito, T. Ishii, 2021, medRxiv.

Safety and Effectiveness of Baricitinib for Rheumatoid Arthritis in Japanese Clinical Practice: 24-Week Results of All-Case Post-Marketing Surveillance.

H. Matsuno, N. Tamura, T. Takeuchi, 2022, Modern rheumatology.